Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

Canada signs agreements for 1.5M courses of Pfizer, Merck COVID-19 antiviral pills

Public Services and Procurement Minister Filomena Tassi announced Friday that pending Health Canada authorization, Canada has signed agreements for one million doses of the Pfizer COVID-19 anti-viral pill and 500,000 courses of the Merck anti-viral pill, with the option to secure up to 500,000 more.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article